World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
80
Citations
29015
World Ranking
1142
National Ranking
101

Medicine

D-Index
83
Citations
30121
World Ranking
15467
National Ranking
1423

Overview

Margaret Johnson is affiliated with The Royal Free Hospital in the United Kingdom. Their academic and professional work is connected to this institution, reflecting a clinical or research focus likely centered around healthcare or medical sciences.

There are no recent papers, frequent co-authors, or specific publication venues listed for Margaret Johnson in the available data. Similarly, there are no recorded book publications or detailed information about main fields, subfields, or specific research topics related to their work.

The absence of published papers, co-author collaborations, and specific fields or topics indicates that publicly accessible bibliometric or research output data on Margaret Johnson is limited or not present in the provided dataset.

There are no awards or distinctions recorded for Margaret Johnson, and the data confirms that they are currently living.

As such, the profile relies on the confirmed affiliation and the factual absence of additional bibliographic and research details, presenting a neutral overview of Margaret Johnson's professional identity within the research and academic community at The Royal Free Hospital.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

    F van Leth;P Phanuphak;K Ruxrungtham;E Baraldi

  • Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

    Sharon Walmsley;Barry Bernstein;Martin King;José Arribas

  • The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization

    K. Dheda;J.F. Huggett;J.S. Chang;L.U. Kim

  • Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

    Adriano Lazzarin;Thomas Campbell;Bonaventura Clotet;Margaret Johnson

  • Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

    Margaret T. May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

    Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg

  • Late presentation of HIV infection: a consensus definition

    A Antinori;T Coenen;D Costagiola;N Dedes

  • Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.

    Calvin J Cohen;Jaime Andrade-Villanueva;Bonaventura Clotet;Jan Fourie

  • Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

    Margaret T May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012

    Ian Williams;Duncan Churchill;Jane Anderson;Marta Boffito

  • Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

    R A M Breen;C J Smith;H Bettinson;S Dart

  • Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

    Charles B Hicks;Pedro Cahn;David A Cooper;Sharon L Walmsley

  • Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

    Helen L. Devereux;Mike Youle;Margaret A. Johnson;Clive Loveday

  • Lung Remodeling in Pulmonary Tuberculosis

    Keertan Dheda;Helen Booth;Jim F. Huggett;Margaret A. Johnson

  • Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.

    Margaret Johnson;Beatriz Grinsztejn;Claudia Rodriguez;Jeffrey Coco

  • Tenofovir-associated renal and bone toxicity

    Clare L N Woodward;A M Hall;I G Williams;S Madge

  • Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study

    Marina Daskalopoulou;Alison Rodger;Andrew N Phillips;Lorraine Sherr

  • Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

    Amanda Mocroft;Michael Youle;Antonia Moore;Caroline A. Sabin

  • Influence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA Study

    Jean-Paul Viard;Amanda Mocroft;Antonio Chiesi;Ole Kirk

Frequent Co-Authors

Caroline Sabin
Caroline Sabin University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Marc Lipman
Marc Lipman Royal Free London NHS Foundation Trust
Martin Fisher
Martin Fisher University of Sussex
Amanda Mocroft
Amanda Mocroft University College London
Paul D. Griffiths
Paul D. Griffiths University College London
Frank A. Post
Frank A. Post King's College London
Brian Gazzard
Brian Gazzard St Bartholomew's Hospital
Richard Gilson
Richard Gilson University College London
Clifford Leen
Clifford Leen Western General Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse healthcare and science careers. Programs such as the shortest online medical billing and coding certificate programs offer quick entry points into the administrative side of healthcare. These programs provide essential skills for managing medical records—an option for those wanting to complement their science background with practical office expertise.

Beyond specialized certificates, numerous online healthcare programs allow students to pursue broader medical careers. These flexible options range from public health to allied health disciplines, accommodating varied interests and schedules.

Students aiming to expand their impact in public health may consider mph online programs with easy admission requirements. These programs often provide foundational knowledge and leadership skills needed to address community health challenges effectively.

Additionally, careers such as becoming a Certified Child Life Specialist can be a meaningful pathway for those passionate about supporting children’s emotional and developmental needs in healthcare settings. Learn about the role’s demand and compensation by exploring the certified child life specialist salary and career outlook.

Best Scientists Citing Margaret Johnson

Trending Scientists